Evidence map›Paper›PMID 30352630›Full record

ArticleActa neuropathologica communications2018

NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.

Michaela Kerstin Müller, Eric Jacobi, Kenji Sakimura, Roberto Malinow, Jakob von Engelhardt

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. C57BL/6 Background Attenuates mHTT Toxicity in the Striatum of YAC128 Mice.International journal of molecular sciences · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. The Toxicity and Polymorphism of β-Amyloid Oligomers.International journal of molecular sciences · 2020
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Michaela Kerstin MüllerInstitute of Pathophysiology, University Medical Center of the Johannes Gutenberg University Mainz, 55128, Mainz, Germany.
Eric JacobiInstitute of Pathophysiology, University Medical Center of the Johannes Gutenberg University Mainz, 55128, Mainz, Germany.
Kenji SakimuraDepartment of Cellular Neurobiology, Brain Research Institute, Niigata University, Niigata, 951-8585, Japan.
Roberto MalinowCenter for Neural Circuits and Behavior, Department of Neuroscience and Section for Neurobiology, Division of Biology, University of California at San Diego, San Diego, CA, USA.
Jakob von EngelhardtInstitute of Pathophysiology, University Medical Center of the Johannes Gutenberg University Mainz, 55128, Mainz, Germany. engelhardt@uni-mainz.de.ORCID 0000-0003-3861-3294
Johannes Gutenberg University Mainz · DENiigata University · JPUniversity of California San Diego · US

Funding

MECHANISMS OF SYNAPTIC LTP--SILENT SYNAPSESR01MH049159 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALINOW, ROBERTO · 1997 to 2019
$4.7M
Novel roles by glutamatergic receptors in the synaptic effects of beta amyloidR01AG032132 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALINOW, ROBERTO · 2008 to 2017
$4.5M
NIA NIH HHS R01 AG032132NIMH NIH HHS R01 MH049159
6 · The paper itself

Abstract

Amyloid beta (Aβ)-mediated synapse dysfunction and spine loss are considered to be early events in Alzheimer's disease (AD) pathogenesis. N-methyl-D-aspartate receptors (NMDARs) have previously been suggested to play a role for Amyloid beta (Aβ) toxicity. Pharmacological block of NMDAR subunits in cultured neurons and mice suggested that NMDARs containing the GluN2B subunit are necessary for Aβ-mediated changes in synapse number and function in hippocampal neurons. Interestingly, NMDARs undergo a developmental switch from GluN2B- to GluN2A-containing receptors. This indicates different functional roles of NMDARs in young mice compared to older animals. In addition, the lack of pharmacological tools to efficiently dissect the role of NMDARs containing the different subunits complicates the interpretation of their specific role. In order to address this problem and to investigate the specific role for Aβ toxicity of the distinct NMDAR subunits in dentate gyrus granule cells of adult mice, we used conditional knockout mouse lines for the subunits GluN1, GluN2A and GluN2B. Aβ-mediated changes in synaptic function and neuronal anatomy were investigated in several-months old mice with virus-mediated overproduction of Aβ and in 1-year old 5xFAD mice. We found that all three NMDAR subunits contribute to the Aβ-mediated decrease in the number of functional synapses. However, NMDARs are not required for the spine number reduction in dentate gyrus granule cells after chronic Aβ-overproduction in 5xFAD mice. Furthermore, the amplitude of synaptic and extrasynaptic NMDAR-mediated currents was reduced in dentate gyrus granule of 5xFAD mice without changes in current kinetics, suggesting that a redistribution or change in subunit composition of NMDARs does not play a role in mediating Amyloid beta (Aβ) toxicity. Our study indicates that NMDARs are involved in AD pathogenesis by compromising synapse function but not by affecting neuron morphology.

Indexed as

Action PotentialsAlzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2Dendritic SpinesDentate GyrusDisease Models, AnimalExcitatory Amino Acid AgentsExcitatory Postsynaptic PotentialsFemaleGene Expression RegulationHEK293 CellsHumansMaleAmyloid beta-PeptidesAmyloid beta-Protein PrecursorCalcium-Calmodulin-Dependent Protein Kinase Type 2Excitatory Amino Acid AgentsPresenilin-1PSEN1 protein, humanReceptors, N-Methyl-D-AspartateAlzheimer’s diseaseAmyloid BetaGluN2AGluN2BNMDA receptor

Identifiers

PMID30352630
PMCPMC6198500
OpenAlexW2897406530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.